Tonira Pharma (Delisted) share price history
BSE: 530155
Last traded ₹19.75 on 29 May 2012
Delisted on 22 Jun 2012.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
May 2012
9 May · Board Meeting on May 16, 2012
Meeting of the Board of Directors of the Company will be held on May 16, 2012, inter-alia, to consider and to take on record: 1. The order ....
Feb 2012
Dec 2011
30 Dec · Outcome of Court Convened Meeting
Pursuant to the Direction of the Hon'able High Court of Gujarat at Ahmedahad, the meetings of the Unsecured Creditors and the Equity Shareholders ....
Nov 2011
Sep 2011
17 Sep · Board meeting
Board of Directors of the Company, on September 17, 2011, have approved merger of Tonira Pharma Limited with Ipca Laboratories Limited with effect ....
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Dec 2011, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹12 Crup 68.90%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.18 CrQuarter to Sep 2011: −₹0.90 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 1.4%
Revenue by year
Peak revenue ₹41 Cr, year to Mar 2009
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2011, −₹2.08 CrA loss in 3 of the 4 years shown
| ₹ crore | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 |
|---|---|---|---|---|---|---|---|
| Revenue | 8.5 | 6.4 | 10.1 | – | 9.8 | 7.3 | 12.4 |
| Net profit | −0.4 | −1.0 | 0.4 | – | −1.6 | −0.9 | 0.2 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −4.6% | −16.3% | 3.9% | – | −16.2% | −12.3% | 1.4% |
Standalone. The last eight quarters. The latest is shaded. No results on record for the quarters to Mar 2010 and Mar 2011.
Where the return came from
Yearly rates to Mar 2011, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −42.3% | – | – | 0.0% |
| 3 years | −11.8% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Recent sessions
The last 10 trading days to 29 May 2012, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 29 May 2012 | 19.90 | 19.90 | 19.00 | 19.75 | 19.55 | 1,831 |
| 28 May 2012 | 19.45 | 19.60 | 19.10 | 19.35 | 19.28 | 736 |
| 25 May 2012 | 19.05 | 19.10 | 18.25 | 19.10 | 18.74 | 6,280 |
| 24 May 2012 | 19.05 | 19.85 | 19.05 | 19.20 | 19.39 | 260 |
| 23 May 2012 | 19.10 | 19.40 | 19.05 | 19.35 | 19.27 | 3,400 |
| 22 May 2012 | 19.25 | 19.35 | 19.00 | 19.00 | 19.15 | 4,003 |
| 21 May 2012 | 19.05 | 20.25 | 19.05 | 19.95 | 19.36 | 1,867 |
| 18 May 2012 | 20.55 | 20.60 | 18.70 | 19.45 | 19.15 | 7,128 |
| 17 May 2012 | 19.30 | 20.00 | 19.30 | 19.65 | 19.92 | 2,959 |
| 16 May 2012 | 20.90 | 21.00 | 20.00 | 20.00 | 20.25 | 2,300 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Tonira Pharma Ltd.
- BSE code
- 530155
- ISIN
- INE844F01012
- Face value
- ₹10
- CIN
- L99999GJ1992PLC018156
- Corporate identity number, the registrar of companies' code for it